Drug & medication recalls Moderate risk

Sandoz product recalled over manufacturing violations

Recall date
September 23, 2019
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Official notice title
Sandoz, Inc recalls Sandoz Ranitidine Hydrochloride Capsules 150mg 500 Capsules Rx Only Manufactured by Sandoz Inc. Princeton, NJ 08540 Pro…
Recall number
D-0128-2020
FDA classification
Class II
Brand / firm
Sandoz, Inc
Sold / distributed
U.S. Nationwide

Why it was recalled

CGMP Deviations: Detection of a trace amount of an unexpected impurity, N-nitrosodimethylamine (NDMA).

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Sandoz Ranitidine Hydrochloride Capsules 150mg 500 Capsules Rx Only Manufactured by Sandoz Inc. Princeton, NJ 08540 Product of India NDC 0781-2855-05

Get recall alerts

Free email alert whenever Sandoz, Inc has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Sandoz, Inc